Literatur
-
1
Motil K J, Grand R J, Maletskos C J, Young V R.
The effect of disease, drug, and diet on whole body protein metabolism in adolescents with Crohn disease and growth failure.
J Pediatr.
1982;
101
345-351
-
2
Rosenberg I H, Bengoa J M, Sitrin M D.
Nutritional aspects of inflammatory bowel disease.
Annu Rev Nutr.
1985;
5
463-484
-
3
Heatley R V.
Assessing nutritional state in inflammatory bowel disease.
Gut.
1986;
27, Suppl 1
61-66
-
4
Beeken W L, Busch H J, Sylwester D L.
Intestinal protein loss in Crohn's disease.
Gastroenterology.
1972;
62
207-215
-
5
Kanof M E, Lake A M, Bayless T M.
Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease.
Gastroenterology.
1988;
95
1523-1527
-
6
Seidman E G.
Nutritional management of inflammatory bowel disease.
Gastroenterol Clin North Am.
1989;
18
129-155
-
7
Seidman E, LeLeiko N, Ament M. et al .
Nutritional issues in pediatric inflammatory bowel disease.
J Pediatr Gastroenterol Nutr.
1991;
12
424-438
-
8
Belli D C, Seidman E, Bouthillier L. et al .
Chronic intermittent elemental diet improves growth failure in children with Crohn's disease.
Gastroenterology.
1988;
94
603-610
-
9
Markowitz J, Grancher K, Rosa J, Aiges H, Daum F.
Growth failure in pediatric inflammatory bowel disease.
J Pediatr Gastroenterol Nutr.
1993;
16
373-380
-
10
Kirschner B S.
Growth and development in chronic inflammatory bowel disease.
Acta Paediatr Scand.
1990;
366, Suppl
98-104
-
11
Hildebrand H, Karlberg J, Kristiansson B.
Longitudinal growth in children and adolescents with inflammatory bowel disease.
J Pediatr Gastroenterol Nutr.
1994;
18
165-173
-
12
Lashner B A.
Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis.
J Cancer Res Clin Oncol.
1993;
119
549-554
-
13
Aiges H, Markowitz J, Rosa J, Daum F.
Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease.
Gastroenterology.
1989;
97
905-910
-
14
Chan A T, Fleming C R, O'Fallon W M, Huizenga K A.
Estimated versus measured basal energy requirements in patients with Crohn's disease.
Gastroenterology.
1986;
91
75-78
-
15
Sjogren A, Floren C H, Nilsson A.
Evaluation of magnesium status in Crohn's disease as assessed by intracellular analysis and intravenous magnesium infusion.
Scand J Gastroenterol.
1988;
23
555-561
-
16
Geerling B J, Badart-Smook A, Stockbrugger R W, Brummer R J.
Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission.
Am J Clin Nutr.
1998;
67
919-926
-
17
Rath H C, Caesar I, Roth M, Scholmerich J.
Nutritional deficiencies and complications in chronic inflammatory bowel diseases.
Med Klin.
1998;
93
6-10
-
18
Maier-Dobersberger T, Lochs H.
Enteral supplementation of phosphate does not prevent hypophosphatemia during refeeding of cachectic patients.
JPEN J Parenter Enteral Nutr.
1994;
18
182-184
-
19
Vogelsang H, Schofl R, Tillinger W, Ferenci P, Gangl A.
25-hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency.
Wien Klin Wochenschr.
1997;
109
678-682
-
20
Schoon E J, Muller M C, Vermeer C, Schurgers L J, Brummer R J, Stockbrugger R W.
Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?.
Gut.
2001;
48
473-477
-
21
Saitoh O, Matsumoto H, Sugimori K. et al .
Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin levels in patients with colorectal diseases.
Digestion.
1995;
56
67-75
-
22
Becker K, Niederau C, Frieling T.
Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
Z Gastroenterol.
1999;
37
597-605
-
23
Hundegger K, Stufler M, Karbach U.
Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin?.
Z Gastroenterol.
1992;
30
722-728
-
24
Mingrone G, Benedetti G, Capristo E. et al .
Twenty-four-hour energy balance in Crohn disease patients: metabolic implications of steroid treatment.
Am J Clin Nutr.
1998;
67
118-123
-
25
Stokes M A, Hill G L.
Total energy expenditure in patients with Crohn's disease: measurement by the combined body scan technique.
JPEN J Parenter Enteral Nutr.
1993;
17
3-7
-
26
O'Morain C, Segal A M, Levi A J, Valman H B.
Elemental diet in acute Crohn's disease.
Arch Dis Child.
1983;
58
44-47
-
27
Azcue M, Rashid M, Griffiths A, Pencharz P B.
Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.
Gut.
1997;
41
203-208
-
28
Rigaud D, Cerf M, Angel A L, Sobhani I, Carduner M J, Mignon M.
Increase of resting energy expenditure during flare-ups in Crohn disease.
Gastroenterol Clin Biol.
1993;
17
932-937
-
29
Schneeweiss B, Lochs H, Zauner C. et al .
Energy and substrate metabolism in patients with active Crohn's disease.
J Nutr.
1999;
129
844-848
-
30
Muller M J, Schmidt L U, Korber J, von zur M A, Canzler H, Schmidt F W.
Reduced metabolic efficiency in patients with Crohn's disease.
Dig Dis Sci.
1993;
38
2001-2009
-
31
Barot L R, Rombeau J L, Feurer I D, Mullen J L.
Caloric requirements in patients with inflammatory bowel disease.
Ann Surg.
1982;
195
214-218
-
32
Geerling B J, Badart-Smook A, Stockbrugger R W, Brummer R J.
Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls.
Eur J Clin Nutr.
2000;
54
514-521
-
33
Semeao E J, Jawad A F, Stouffer N O, Zemel B S, Piccoli D A, Stallings V A.
Risk factors for low bone mineral density in children and young adults with Crohn's disease.
J Pediatr.
1999;
135
593-600
-
34
Issenman R M.
Bone mineral metabolism in pediatric inflammatory bowel disease.
Inflamm Bowel Dis.
1999;
5
192-199
-
35
Capristo E, De Gaetano A, Mingrone G. et al .
Multivariate identification of metabolic features in inflammatory bowel disease.
Metabolism.
1999;
48
952-956
-
36
Harries A D, Brown R, Heatley R V, Williams L A, Woodhead S, Rhodes J.
Vitamin D status in Crohn's disease: association with nutrition and disease activity.
Gut.
1985;
26
1197-1203
-
37
Haugeberg G, Vetvik K, Stallemo A, Bitter H, Mikkelsen B, Stokkeland M.
Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study.
Scand J Gastroenterol.
2001;
36
759-765
-
38
Bernstein C N, Seeger L L, Sayre J W, Anton P A, Artinian L, Shanahan F.
Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
J Bone Miner Res.
1995;
10
250-256
-
39
Stockbrugger R W, Schoon E J, Bollani S. et al .
Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease.
Aliment Pharmacol Ther.
2002;
16
1519-1527
-
40
Klaus J, Armbrecht G, Steinkamp M. et al .
High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease.
Gut.
2002;
51
654-658
-
41
Habtezion A, Silverberg M S, Parkes R, Mikolainis S, Steinhart A H.
Risk factors for low bone density in Crohn's disease.
Inflamm Bowel Dis.
2002;
8
87-92
-
42
Bernstein C N, Blanchard J F, Leslie W, Wajda A, Yu B N.
The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study.
Ann Intern Med.
2000;
133
795-799
-
43
Cucino C, Sonnenberg A.
Cause of death in patients with inflammatory bowel disease.
Inflamm Bowel Dis.
2001;
7
250-255
-
44
Lindor K D, Fleming C R, Ilstrup D M.
Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn's disease.
Mayo Clin Proc.
1985;
60
393-396
-
45
Higgens C S, Keighley M R, Allan R N.
Impact of preoperative weight loss and body composition changes on postoperative outcome in surgery for inflammatory bowel disease.
Gut.
1984;
25
732-736
-
46
Motil K J, Grand R J, Davis-Kraft L, Ferlic L L, Smith E O.
Growth failure in children with inflammatory bowel disease: a prospective study.
Gastroenterology.
1993;
105
681-691
-
47
Messori A, Trallori G, D'Albasio G, Milla M, Vannozzi G, Pacini F.
Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis.
Scand J Gastroenterol.
1996;
31
267-272
-
48
Griffiths A M, Ohlsson A, Sherman P M, Sutherland L R.
Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease.
Gastroenterology.
1995;
108
1056-1067
-
49 Zachos M, Tondeur M, Griffiths A M. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2001 3 CD 000542
-
50
O'Morain C, Segal A W, Levi A J.
Elemental diet as primary treatment of acute Crohn's disease: a controlled trial.
Br Med J (Clin Res Ed).
1984;
288
1859-1862
-
51
Gorard D A, Hunt J B, Payne-James J J. et al .
Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone.
Gut.
1993;
34
1198-1202
-
52
Lindor K D, Fleming C R, Burnes J U, Nelson J K, Ilstrup D M.
A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn's disease.
Mayo Clin Proc.
1992;
67
328-333
-
53
Gonzalez-Huix F, de Leon R, Fernandez-Banares F. et al .
Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.
Gut.
1993;
34
778-782
-
54
Malchow H, Steinhardt H J, Lorenz-Meyer H. et al .
Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III.
Scand J Gastroenterol.
1990;
25
235-244
-
55
Lochs H, Steinhardt H J, Klaus-Wentz B. et al .
Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV.
Gastroenterology.
1991;
101
881-888
-
56
Seidman E, Griffiths A, Jones A, Issenman R.
Semielemental diet versus prednisone in the treatment of active Crohns's disease in children and adolescents.
Gastroenterology.
1993;
104
A778 (Abstract)
-
57
Le Quintrec Y, Cosnes J, Le Quintrec M. et al .
Exclusive elemental enteral diet in cortico-resistant and cortico-dependent forms of Crohn's disease.
Gastroenterol Clin Biol.
1987;
11
477-482
-
58
Greenberg G R, Fleming C R, Jeejeebhoy K N, Rosenberg I H, Sales D, Tremaine W J.
Controlled trial of bowel rest and nutritional support in the management of Crohn's disease.
Gut.
1988;
29
1309-1315
-
59
Lochs H, Egger-Schödl M, Pötzi R, Kappel C H, Schuh R.
Enterale Ernährung - eine Alternative zur parenteralen Ernährung in der Behandlung von Morbus Crohn?.
Leber, Magen, Darm.
1984;
14
64-67
-
60
Lochs H, Meryn S, Marosi L, Ferenci P, Hörtnagl H.
Has total bowel rest a beneficial effect in the treatment of Crohn's Disease?.
Clin Nutr.
1983;
2
61-64
-
61
Wright R A, Adler E C.
Peripheral parenteral nutrition is no better than enteral nutrition in acute exacerbation of Crohn's disease: a prospective trial.
J Clin Gastroenterol.
1990;
12
396-399
-
62
Verma S, Kirkwood B, Brown S, Giaffer M H.
Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease.
Dig Liver Dis.
2000;
32
769-774
-
63
Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A.
Supplementary enteral nutrition maintains remission in paediatric Crohn's disease.
Gut.
1996;
38
543-548
-
64
Hirakawa H, Fukuda Y, Tanida N, Hosomi M, Shimoyama T.
Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn's disease.
Gastroenterol Jpn.
1993;
28
379-384
-
65
Royall D, Jeejeebhoy K N, Baker J P. et al .
Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome.
Gut.
1994;
35
783-787
-
66
Harries A D, Jones L A, Danis V. et al .
Controlled trial of supplemented oral nutrition in Crohn's disease.
Lancet.
1983;
1
887-890
-
67
Blondel-Kucharski F, Chircop C, Marquis P. et al .
Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients.
Am J Gastroenterol.
2001;
96
2915-2920
-
68
Malone M.
Quality of life of patients receiving home parenteral or enteral nutrition support.
Pharmacoeconomics.
1994;
5
101-108
-
69
Rees R G, Keohane P P, Grimble G K, Frost P G, Attrill H, Silk D B.
Elemental diet administered nasogastrically without starter regimens to patients with inflammatory bowel disease.
JPEN J Parenter Enteral Nutr.
1986;
10
258-262
-
70
Mahajan L, Oliva L, Wyllie R, Fazio V, Steffen R, Kay M.
The safety of gastrostomy in patients with Crohn's disease.
Am J Gastroenterol.
1997;
92
985-988
-
71
Cosgrove M, Jenkins H R.
Experience of percutaneous endoscopic gastrostomy in children with Crohn's disease.
Arch Dis Child.
1997;
76
141-143
-
72
Anstee Q M, Forbes A.
The safe use of percutaneous gastrostomy for enteral nutrition in patients with Crohn's disease.
Eur J Gastroenterol Hepatol.
2000;
12
1089-1093
-
73
Verma S, Brown S, Kirkwood B, Giaffer M H.
Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial.
Am J Gastroenterol.
2000;
95
735-739
-
74
Mansfield J C, Giaffer M H, Holdsworth C D.
Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease.
Gut.
1995;
36
60-66
-
75
Park H R, Galloway A, Danesh J ZD, Russell R.
Double-blind controlled trial of elemental and polymeric diets as primary therapy in actice Crohn's disease.
Eur J Gastroenterol Hepatol.
1991;
3
483-490
-
76
Middleton S J, Riordan A M, Hunter .
Comparison of elemental and peptide-based diets in the treatment of acute Crohn's disease.
Ital J Gastroenterol.
1991;
23
609A
-
77
Raouf A H, Hildrey V, Daniel J. et al .
Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge.
Gut.
1991;
32
702-707
-
78
Rigaud D, Cosnes J, Le Quintrec Y, Rene E, Gendre J P, Mignon M.
Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet.
Gut.
1991;
32
1492-1497
-
79
Sakurai T, Matsui T, Yao T. et al .
Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas.
JPEN J Parenter Enteral Nutr.
2002;
26
98-103
-
80
Khoshoo V, Reifen R, Neuman M G, Griffiths A, Pencharz P B.
Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn's disease.
JPEN J Parenter Enteral Nutr.
1996;
20
401-405
-
81
Gassull M A, Fernandez-Banares F, Cabre E. et al .
Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.
Gut.
2002;
51
164-168
-
82
Akobeng A K, Miller V, Stanton J, Elbadri A M, Thomas A G.
Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease.
J Pediatr Gastroenterol Nutr.
2000;
30
78-84
-
83
Den Hond E, Hiele M, Peeters M, Ghoos Y, Rutgeerts P.
Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease.
JPEN J Parenter Enteral Nutr.
1999;
23
7-11
-
84
Beattie R M, Schiffrin E J, Donnet-Hughes A. et al .
Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease.
Aliment Pharmacol Ther.
1994;
8
609-615
-
85
Fell J M, Paintin M, Arnaud-Battandier F. et al .
Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease.
Aliment Pharmacol Ther.
2000;
14
281-289
-
86
Capristo E, Mingrone G, Addolorato G, Greco A V, Gasbarrini G.
Metabolic features of inflammatory bowel disease in a remission phase of the disease activity.
J Intern Med.
1998;
243
339-347
-
87
Klein S, Meyer S, O'Sullivan P.
The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balance.
J Clin Gastroenterol.
1988;
10
34-40
-
88
Schreiber J, Shurin S B.
Oral care with vancomycin paste for alpha-hemolytic streptococcal sepsis.
J Pediatr Hematol Oncol.
1996;
18
334
-
89
Rath H C, Caesar I, Roth M, Scholmerich J.
Nutritional deficiencies and complications in chronic inflammatory bowel diseases.
Med Klin.
1998;
93
6-10
-
90
Franklin J L, Rosenberg H H.
Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine).
Gastroenterology.
1973;
64
517-525
-
91
Lashner B A.
Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis.
J Cancer Res Clin Oncol.
1993;
119
549-554
-
92
Boot A M, Bouquet J, Krenning E P, de Muinck Keizer-Schrama S M.
Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.
Gut.
1998;
42
188-194
-
93
Jahnsen J, Falch J A, Aadland E, Mowinckel P.
Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.
Gut.
1997;
40
313-319
-
94
Brandes J W, Stenner A, Martini G A.
Dietary habits of patients with ulcerative colitis.
Z Gastroenterol.
1997;
17
834-842
-
95
Jones L A, Harries A D, Rhodes J, Heatley R V.
Normal energy intake in undernourished patients with Crohn's disease.
Br Med J (Clin Res Ed).
1984;
288
193
-
96
Tragnone A, Valpiani D, Miglio F. et al .
Dietary habits as risk factors for inflammatory bowel disease.
Eur J Gastroenterol Hepatol.
1995;
7
47-51
-
97
Rocchio M A, Cha C J, Haas K F, Randall H T.
Use of chemically defined diets in the management of patients with acute inflammatory bowel disease.
Am J Surg.
1974;
127
469-475
-
98
Axelsson C, Jarnum S.
Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease.
Scand J Gastroenterol.
1977;
12
89-95
-
99
McIntyre P B, Powell-Tuck J, Wood S R. et al .
Controlled trial of bowel rest in the treatment of severe acute colitis.
Gut.
1986;
27
481-485
-
100
Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M. et al .
Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis.
Am J Gastroenterol.
1993;
88
227-232
-
101
Stenson W F, Cort D, Rodgers J. et al .
Dietary supplementation with fish oil in ulcerative colitis.
Ann Intern Med.
1992;
116
609-614
-
102
Hawthorne A B, Daneshmend T K, Hawkey C J. et al .
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.
Gut.
1992;
33
922-928
-
103
Loeschke K, Ueberschaer B, Pietsch A. et al .
N-3 fatty acids only delay early relapse of ulcerative colitis in remission.
Dig Dis Sci.
1996;
41
2087-2094
-
104
Purdum P P, Kirby D F.
Short-bowel syndrome: a review of the role of nutrition support.
JPEN J Parenter Enteral Nutr.
1991;
15
93-101
-
105
Marotta R, Floch M H.
Dietary therapy of steatorhoea.
Gastroenterol Clin North Am.
1993;
18
485-508
-
106
Nightingale J M, Lennard-Jones J E.
The short bowel syndrome: what's new and old?.
Dig Dis.
1993;
11
12-31
-
107
Messing B, Pigot F, Rongier M, Morin M C, Ndeindoum U, Rambaud J C.
Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome.
Gastroenterology.
1991;
100
1502-1508
-
108
Jeppesen P B, Mortensen P B.
Intestinal failure defined by measurements of intestinal energy and wet weight absorption.
Gut.
2000;
46
701-706
-
109
Woolf G M, Miller C, Kurian R, Jeejeebhoy K N.
Nutritional absorption in short bowel syndrome. Evaluation of fluid, calorie, and divalent cation requirements.
Dig Dis Sci.
1987;
32
8-15
-
110
Nordgaard I, Hansen B S, Mortensen P B.
Colon as a digestive organ in patient with short bowel.
Lancet.
1994;
343
373-376
-
111
Ovensen L, Chu R, Howard L.
The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome.
Am J Clin Nutr.
1983;
38
270-278
-
112
Cosnes J, Gendre J P, Evard D, Le Quintrec Y.
Compensatory enteral hyperalimentation for management of patients with severe short bowel syndrome.
Am J Clin Nutr.
1985;
41
1002-1009
-
113
Booth I W.
Enteral nutrition as primary therapy in short bowel syndrome.
Gut.
1994;
35
S69-S72
-
114
Carbonnel F, Cosnes J, Chevret S. et al .
The role of anatomic factors in nutritional autonomy after extensive small bowel resection.
JPEN J Parenter Enteral Nutr.
1996;
20
275-280
-
115
Rabast U.
Ernährungstherapie beim Kurzdarmsyndrom.
Akt Ernaehr Med.
1997;
22
103-111
-
116
Rodriguez D J, Clevenger F W.
Successful enteral refeeding after massive small bowel resection.
West J Med.
1993;
159
192-194
-
117
Dudrick S J, Latifi R, Fosnocht D E.
Management of the short-bowel syndrome.
Surg Clin North Am.
1991;
71
625-643
-
118
Griffin G E, Fagan E F, Hodgson H J, Chadwick V S.
Enteral therapy in the management of massive gut resection complicated by chronic fluid and electrolyte depletion.
Dig Dis Sci.
1982;
27
902-908
-
119
Lennard-Jones J E.
Review article: practical management of the short bowel.
Aliment Pharmacol Ther.
1994;
8
563-577
-
120
McIntyre P B, Fitchew M, Lennard-Jones J E.
Patients with a high jejunostomy do not need a special diet.
Gastroenterology.
1986;
91
25-33
-
121
Suchner U, Senftleben U, Eckart T. et al .
Enteral versus parenteral nutrition: effects on gastrointestinal function and metabolism.
Nutrition.
1996;
12
13-22
-
122
Wicks C, Somasundaram S, Bjarnason I. et al .
Comparison of enteral feeding and total parenteral nutrition after liver transplantation.
Lancet.
1994;
344
837-840
-
123
Hadfield R J, Sinclair D G, Houldsworth P E, Evans T W.
Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill.
Am J Respir Crit Care Med.
1995;
152
1545-1548
-
124
Reynolds J V, Kanwar S, Welsh F K. et al .
Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery?.
JPEN J Parenter Enteral Nutr.
1997;
21
196-201
-
125
Hoensch H P, Steinhardt H J, Weiss G, Haug D, Maier A, Malchow H.
Effects of semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small intestinal mucosa in humans.
Gastroenterology.
1984;
86
1519-1530
-
126
Lipman T O.
Grains or veins: is enteral nutrition really better than parenteral nutrition? A look at the evidence.
JPEN J Parenter Enteral Nutr.
1998;
22
167-182
-
127
Cosnes J, Carbonnel F.
Oral and enteral nutrition management and drug treatment of short bowel syndrome.
Clin Nutr.
1995;
14
16-20
-
128
Wilmore D W, Robinson M K.
Short bowel syndrome.
World J Surg.
2000;
24
1486-1492
-
129
Byrne T A, Persinger R L, Young L S, Ziegler T R, Wilmore D W.
A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet.
Ann Surg.
1995;
222
243-254
-
130
Scolapio J S, McGreevy K, Tennyson G S, Burnett O L.
Effect of glutamine in short-bowel syndrome.
Clin Nutr.
2001;
20
319-323
-
131
Li L, Irving M.
The effectiveness of growth hormone, glutamine and a low-fat diet containing high-carbohydrate on the enhancement of the function of remnant intestine among patients with short bowel syndrome: a review of published trials.
Clin Nutr.
2001;
20
199-204
-
132
Shaw J H, Wolfe R R.
Glucose, fatty acid, and urea kinetics in patients with severe pancreatitis. The response to substrate infusion and total parenteral nutrition.
Ann Surg.
1986;
204
665-672
-
133
Dickerson R N, Vehe K L, Mullen J L, Feurer I D.
Resting energy expenditure in patients with pancreatitis 1.
Crit Care Med.
1991;
19
484-490
-
134
Bouffard Y H, Delafosse B X, Annat G J, Viale J P, Bertrand O M, Motin J P.
Energy expenditure during severe acute pancreatitis 1.
JPEN J Parenter Enteral Nutr.
1989;
13
26-29
-
135
Feller J H, Brown R A, Toussaint G P, Thompson A G.
Changing methods in the treatment of severe pancreatitis 1.
Am J Surg.
1974;
127
196-201
-
136
Sitzmann J V, Steinborn P A, Zinner M J, Cameron J L.
Total parenteral nutrition and alternate energy substrates in treatment of severe acute pancreatitis 1.
Surg Gynecol Obstet.
1989;
168
311-317
-
137
Cameron J L, Capuzzi D M, Zuidema G D, Margolis S.
Acute pancreatitis with hyperlipemia. Evidence for a persistent defect in lipid metabolism 1.
Am J Med.
1974;
56
482-487
-
138
Cameron J L, Capuzzi D M, Zuidema G D, Margolis S.
Acute pancreatitis with hyperlipemia: the incidence of lipid abnormalities in acute pancreatitis 1.
Ann Surg.
1973;
177
483-489
-
139
Greenberger N J.
Pancreatitis and hyperlipemia 1.
N Engl J Med.
1973;
289
586-587
-
140
Robin A P, Campbell R, Palani C K, Liu K, Donahue P E, Nyhus L M.
Total parenteral nutrition during acute pancreatitis: clinical experience with 156 patients 1.
World J Surg.
1990;
14
572-579
-
141
Sax H C, Warner B W, Talamini M A. et al .
Early total parenteral nutrition in acute pancreatitis: lack of beneficial effects 1.
Am J Surg.
1987;
153
117-124
-
142
McClave S A, Greene L M, Snider H L. et al .
Comparison of the safety of early enteral vs parenteral nutrition in mild acute pancreatitis 4.
JPEN J Parenter Enteral Nutr.
1997;
21
14-20
-
143
Windsor A C, Kanwar S, Li A G. et al .
Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis 1.
Gut.
1998;
42
431-435
-
144
Powell J J, Murchison J T, Fearon K C, Ross J A, Siriwardena A K.
Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis 1.
Br J Surg.
2000;
87
1375-1381
-
145
Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos C A.
Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial 1.
Br J Surg.
1997;
84
1665-1669
-
146
Cravo M, Camilo M E, Marques A, Pinto Correia J.
Early tube feeding in acute pancreatitis: A prospective study.
Clin Nutr.
1989;
8, Suppl 1
7-14
-
147
Kudsk K A, Campbell S M, O’Brien T, Fuller R.
Postoperative jejunal feedings following complicated pancreatitis 1.
Nutr Clin Pract.
1990;
5
14-17
-
148
Nakad A, Piessevaux H, Marot J C. et al .
Is early enteral nutrition in acute pancreatitis dangerous? About 20 patients fed by an endoscopically placed nasogastrojejunal tube 1.
Pancreas.
1998;
17
187-193
-
149
Stabile B E, Debas H T.
Intravenous versus intraduodenal amino acids, fats, and glucose as stimulants of pancreatic section.
Surg Forum.
1981;
32
224-226
-
150
Blackburn G L, Williams L F, Bistrian B R. et al .
New approaches to the management of severe acute pancreatitis 4.
Am J Surg.
1976;
131
114-124
-
151
Grant J P, James S, Grabowski V, Trexler K M.
Total parenteral nutrition in pancreatic disease 3.
Ann Surg.
1984;
200
627-631
-
152
Simpson W G, Marsano L, Gates L.
Enteral nutritional support in acute alcoholic pancreatitis 1.
J Am Coll Nutr.
1995;
14
662-665
-
153
Levy P, Heresbach D, Pariente E A. et al .
Frequency and risk factors of recurrent pain during refeeding in patients with acute pancreatitis: a multivariate multicentre prospective study of 116 patients 1.
Gut.
1997;
40
262-266
-
154
Neviackas J A, Kerstein M D.
Pancreatic enzyme response with an elemental diet 1.
Surg Gynecol Obstet.
1976;
142
71-74
-
155
McArdle A H, Echave W, Brown R A, Thompson A G.
Effect of elemental diet on pancreatic secretion 1.
Am J Surg.
1974;
128
690-692
-
156
Cassim M M, Allardyce D B.
Pancreatic secretion in response to jejunal feeding of elemental diet.
Ann Surg.
1974;
180
228-231
-
157
Grant J P, Davey-McCrae J, Snyder P J.
Effect of enteral nutrition on human pancreatic secretions 2.
JPEN J Parenter Enteral Nutr.
1987;
11
302-304
-
158
Vison N, Hecketsweiler P, Butel J, Bernier J J.
Effect of continuous jejunal perfusion of elemental and complex nutritional solutions on pancreatic enzyme secretion in human subjects 1.
Gut.
1978;
19
194-198
-
159
Ragins H, Levenson S M, Signer R, Stamford W, Seifter E.
Intrajejunal administration of an elemental diet at neutral pH avoids pancreatic stimulation. Studies in dog and man 1.
Am J Surg.
1973;
126
606-614
-
160
Trice S, Melnik G, Page C P.
Complications and costs of early postoperative parenteral versus enteral nutrition in trauma patients.
Nutr Clin Pract.
1997;
12
114-119
-
161
Heyland D K, Novak F, Drover J W, Jain M, Su X, Suchner U.
Should immunonutrition become routine in critically ill patients? A systematic review of the evidence 1.
JAMA.
2001;
286
944-953
-
162
DiMagno E P, Go V L, Summerskill W H.
Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency 15.
N Engl J Med.
1973;
288
813-815
-
163 DiMagno E P, Layer P. Human exocrine pankreatic enzyme secretion. In: Go VL (ed) The pancreas. Biology, pathobiology, and disease. New York; Raven Press 1993: 275-300
-
164
Lanspa S J, Chan A T, Bell J S, Go V L, Dickson E R, DiMagno E P.
Pathogenesis of steatorrhea in primary biliary cirrhosis 1.
Hepatology.
1985;
5
837-842
-
165
Hebuterne X, Hastier P, Peroux J L, Zeboudj N, Delmont J P, Rampal P.
Resting energy expenditure in patients with alcoholic chronic pancreatitis 1.
Dig Dis Sci.
1996;
41
533-539
-
166 DiMagno E P, Clain J E, Layer P. Chronic pancreatitis. In: Go VL (ed) The pancreas. Biology, pathobiology, and disease. New York; Raven Press 1993: 665-706
-
167
Twersky Y, Bank S.
Nutritional deficiencies in chronic pancreatitis 1.
Gastroenterol Clin North Am.
1989;
18
543-565
-
168
Steer M L, Waxman I, Freedman S.
Chronic pancreatitis 4.
N Engl J Med.
1995;
332
1482-1490
-
169
Havala T, Shronts E, Cerra F.
Nutritional support in acute pancreatitis 1.
Gastroenterol Clin North Am.
1989;
18
525-542
-
170
Holt S.
Chronic pancreatitis 3.
South Med J.
1993;
86
201-207
-
171
Latifi R, McIntosh J K, Dudrick S J.
Nutritional management of acute and chronic pancreatitis 1.
Surg Clin North Am.
1991;
71
579-595
-
172
DiMagno E P.
Medical treatment of pancreatic insufficiency 7.
Mayo Clin Proc.
1979;
54
435-442
-
173
Scolapio J S, Malhi-Chowla N, Ukleja A.
Nutrition supplementation in patients with acute and chronic pancreatitis 1.
Gastroenterol Clin North Am.
1999;
28
695-707
-
174
Caliari S, Benini L, Sembenini C, Gregori B, Carnielli V, Vantini I.
Medium-chain triglyceride absorption in patients with pancreatic insufficiency 1.
Scand J Gastroenterol.
1996;
31
90-94
-
175
DiMagno E P, Malagelada J R, Go V L, Moertel C G.
Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules 2.
N Engl J Med.
1977;
296
1318-1322
-
176
Graham D Y.
Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts 5.
N Engl J Med.
1977;
296
1314-1317
-
177
Whitehead A M.
Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations 1.
Pharm Weekbl Sci.
1988;
10
12-16
-
178
Regan P T, Malagelada J R, DiMagno E P, Glanzman S L, Go V L.
Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency 2.
N Engl J Med.
1977;
297
854-858
-
179
Suzuki A, Mizumoto A, Sarr M G, DiMagno E P.
Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea? 2.
Gastroenterology.
1997;
112
2048-2055
-
180
Malesci A, Mariani A, Mezzi G, Bocchia P, Basilico M.
New enteric-coated high-lipase pancreatic extract in the treatment of pancreatic steatorrhea 1.
J Clin Gastroenterol.
1994;
18
32-35
-
181
Taubin H L, Spiro H M.
Nutritional aspects of chronic pancreatitis 1.
Am J Clin Nutr.
1973;
26
367-373
-
182
Heijerman H G, Lamers C B, Bakker W.
Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis 3.
Ann Intern Med.
1991;
114
200-201
-
183
Halgreen H, Pedersen N T, Worning H.
Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis 2.
Scand J Gastroenterol.
1986;
21
104-108
-
184
Ramo O J, Puolakkainen P A, Seppala K, Schroder T M.
Self-administration of enzyme substitution in the treatment of exocrine pancreatic insufficiency 1.
Scand J Gastroenterol.
1989;
24
688-692
-
185
Sampson H A.
Food allergy. Part 1: Immunopathogenesis and clinical disorders.
J Allergy Clin Immunol.
1999;
103
717-728
-
186
Bischoff S C, Manns M P.
Nahrungsmittelallergien.
Internist.
2001;
42
1108-1117
-
187
Bischoff S C, Herrmann A, Mayer J, Manns M P.
Food allergy in patients with gastrointestinal disease.
Monogr Allergy.
1996;
32
130-142
-
188
Bruijnzeel-Koomen C, Ortolani C, Aas K, Bindslev-Jensen C, Björkstén B, Moneret-Vautrin D, Wüthrich B.
Adverse reactions to food.
Allergy.
1995;
50
623-635
-
189
Schoetzau A, Gehring U, Wichmann H.
Prospective cohort studies using hydrolysed formulas for allergy prevention in atopy-prone newborns: a systematic review.
Eur J Pediatr.
2001;
160
323-332
-
190
Niggemann B, Binder C, Dupont C, Hadji S, Arvola T, Isolauri E.
Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis.
Pediatr Allergy Immunol.
2001;
12
78-82
-
191
Munkvad M, Danielsen L, Hoj L, Povlsen C O, Secher L, Svejgaard E, Bundgaard A, Larsen P O.
Antigen-free diet in adult patients with atopic dermatitis. A double-blind controlled study.
Acta Derm Venereol.
1984;
64
524-528
-
192
Hoj L, Osterballe O, Bundgaard A, Weeke B, Weiss M.
A double-blind controlled trial of elemental diet in severe, perennial asthma.
Allergy.
1981;
36
257-262
Prof. Dr. med. Heinrich Lübke
Zentralklinik Emil von Behring · Department Behring Krankenhaus
Gimpelsteig 3 - 3
14165 Berlin
Email: hlueb@zedat.fu-berlin.de
